Market Tracker

07/30 7:55am ET

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

15.26
Delayed Data
As of Jul 29
 -0.46 / -2.93%
Today’s Change
7.85
Today|||52-Week Range
16.83
+25.49%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close15.72
Today’s open15.63
Day’s range-- - --
Volume705,871
Average volume (3 months)914,395
Market cap$1.1B
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)-50.74%
Earnings growth (next 5 years)-22.83%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book14.96

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-1.02-3.09%
ADAPAdaptimmune Therapeu...+0.96+6.27%
FMIFoundation Medicine ...-0.72-2.40%
CHRSCoherus Biosciences ...-0.70-1.94%
Data as of 07/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Chief Financial Officer, Treasurer, CAO &
SVP
Thomas R. Staab
Corporate headquarters
Birmingham, Alabama

Forecasts